OBD presents it first results from its programme on stratifying blood based ALS biomarkers at the Annual 2015 ALS Consortium Conference in Tampa, Florida. The work has been undertaken in collaboration with The North East ALS Consortium (NEALS) and Professor Merit Cudkowicz, Massachusetts General Hospital and Harvard Medical School.